Clinical Trials
2 trialsNCT04697446 2021-08-10
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
Unknown
NCT02913365 2016-09-23
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
Université de Sherbrooke
Unknown